Learn More
Medchemexpress LLC 4-(2-methyl-3-propan-2-ylimidazol-4-yl)-N-(4-methylsulfonylphenyl)pyrimidin-2-amine | 602306-29-6 | MFCD11112135 | 99.9% | 371.46 g/mol | C18H21N5O2S | 500 MG

Supplier: Medchemexpress LLC HY10012500MG
AZD-5438 is a small-molecule inhibitor of cyclin-dependent kinases CDK1, CDK2, and CDK9, characterized by low nanomolar potency in biochemical assays. It is used in research on cell-cycle regulation, cancer pharmacology, and radiosensitization studies, and has a molecular formula of C18H21N5O2S with a molecular weight of 371.46 g/mol.
- Potent inhibition of CDK1, CDK2, and CDK9 with reported IC50s of 16 nM, 6 nM, and 20 nM.
- High purity (>99.9% by HPLC) suitable for biochemical and cell-based assays.
- Supplied as a 500 mg research-grade solid for laboratory use.
- Molecular formula C18H21N5O2S and molecular weight 371.46 g/mol for precise dosing and calculations.
- Applicable for studies of cell-cycle regulation, cancer mechanisms, and radiosensitization.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.